Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2003
03/27/2003CA2461074A1 Methods and compositions of novel triazine compounds
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2445513A1 Benzimidazole derivatives
03/26/2003WO2002026732A1 Benzodiazepine derivative
03/26/2003EP1295880A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
03/26/2003EP1295878A1 Novel pyrazinone derivatives
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294710A1 Indole derivatives useful for the treatment of cns disorders
03/26/2003EP1294709A2 Quinoline derivatives and their use as aurora 2 kinase inhibitors
03/26/2003EP1294708A1 Quinophthalone-derivative based crystallization modifiers
03/26/2003EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1159269B1 Anti-imflammatory indole derivatives
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP1021432B1 Halogen substituted tetracyclic tetrahydrofuran derivatives
03/26/2003EP0984958B1 Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0804418B1 Platelet aggregation inhibitors
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
03/26/2003CN1406231A Pyrimidine compounds
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405166A Thalidomide and its derivatives preparation method
03/26/2003CN1405157A Novel diazo alcoholic antifungal compound and its salt
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103771C Method for preparing 1-(2-pyridyl) Pyrazole compound
03/26/2003CN1103770C Quino xaline diones
03/26/2003CN1103769C Tricyclic amine derivatives
03/26/2003CN1103763C Process for preparation of substituted pyrimidines
03/26/2003CN1103761C Process for producing 1-substituted-hydantoins
03/26/2003CN1103759C Processes for preparing pesticidal intermediates
03/26/2003CN1103758C Process for preparation of drylamides of heteroaromatic carboxylic acids
03/26/2003CA2423902A1 Benzodiazepine derivative
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538006 N-heterocyclic moiety-containing hydroxyethylamine protease inhibitor compounds, methods for making the compounds, and intermediates useful in the method. Also, a method for inhibiting retroviral proteases and for treatment of
03/25/2003US6538002 In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3. as antiinflammatory agents
03/25/2003US6537993 Compounds for enhancing chemotherapy
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537959 Diazacycloalkanes, i.e., 1,4,6-trimethyl-6-(n-(pyridin-2-ylmethyl)-N-methylamino)-1,4 -diazacycloheptane; ligands in manganese, iron and cobalt transition metal complexes.
03/25/2003US6537948 Uracil compounds and use thereof
03/25/2003US6537520 Diagnosis and treatment of cancer; kit containing compound having peptide or peptidomimetic functionality that binds to a alpha v beta 3 receptor linked to a chelator
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022834A1 Method for synthesis of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione
03/20/2003WO2003022833A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022832A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022831A1 4-alkyl-substitute thienyloxy-pyridines
03/20/2003WO2003022815A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022809A2 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022274A2 2-aroylimidazole compounds for treating cancer
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022055A1 Pesticidal compositions
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003WO2002058635A3 Nicotine immunogens and antibodies and uses thereof
03/20/2003WO2002051810A3 Integrin receptor ligands
03/20/2003US20030055266 Small molecule modulators of G protein-coupled receptors
03/20/2003US20030055259 Method for producing 5-aryl nicotinaldehydes
03/20/2003US20030055255 Synthesis of substituted imidazoles
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055244 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055087 As analgesic
03/20/2003US20030055085 For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease
03/20/2003US20030055082 For use in therapy
03/20/2003US20030055081 For therapy of migraine
03/20/2003US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells
03/20/2003US20030055064 Piperazine compounds and medicinal use thereof
03/20/2003US20030055063 R-6-hydroxy-buspirone
03/20/2003US20030055062 Heteroaryl urea neuropeptide Y Y5 receptor antagonists
03/20/2003US20030055057 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutial agents as well as pharmaceutical preparations that contain these derivatives
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1080